Lin L - Search Results

1

Serum ribonucleotide reductase M2 is a potential biomarker for diagnosing and monitoring liver fibrosis in chronic hepatitis B patients.

Zhan Y, Tao Q, Lang Z, Lin L, Li X, Yu S, Yu Z, Zhou G, Wu K, Zhou Z, Yu Z, Zheng J. Zhan Y, et al. Among authors: lin l. J Med Virol. 2023 Oct;95(10):e29157. doi: 10.1002/jmv.29157. J Med Virol. 2023. PMID: 37814947

2

Kaempferol Inhibits Hepatic Stellate Cell Activation by Regulating miR-26b-5p/Jag1 Axis and Notch Pathway.

Zhou G, Li C, Zhang R, Zhan Y, Lin L, Lang Z, Tao Q, Zheng J. Zhou G, et al. Among authors: lin l. Front Pharmacol. 2022 Jun 1;13:881855. doi: 10.3389/fphar.2022.881855. eCollection 2022. Front Pharmacol. 2022. PMID: 35721153 Free PMC article.

3

A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma.

Yang Z, Li X, Pan C, Li Y, Lin L, Jin Y, Zheng J, Yu Z. Yang Z, et al. Among authors: lin l. BMC Cancer. 2022 Dec 22;22(1):1344. doi: 10.1186/s12885-022-10463-0. BMC Cancer. 2022. PMID: 36550445 Free PMC article.

4

LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition.

Zhan Y, Tao Q, Meng Q, Zhang R, Lin L, Li X, Zheng L, Zheng J. Zhan Y, et al. Among authors: lin l. Commun Biol. 2023 Mar 18;6(1):285. doi: 10.1038/s42003-023-04670-z. Commun Biol. 2023. PMID: 36934152 Free PMC article.

5

Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma.

Wang X, Chen J, Lin L, Li Y, Tao Q, Lang Z, Zheng J, Yu Z. Wang X, et al. Among authors: lin l. BMC Cancer. 2023 Mar 28;23(1):284. doi: 10.1186/s12885-023-10766-w. BMC Cancer. 2023. PMID: 36978017 Free PMC article.

6

Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells.

Lang Z, Li Y, Lin L, Li X, Tao Q, Hu Y, Bao M, Zheng L, Yu Z, Zheng J. Lang Z, et al. Among authors: lin l. Cell Death Discov. 2023 Aug 19;9(1):304. doi: 10.1038/s41420-023-01602-y. Cell Death Discov. 2023. PMID: 37598186 Free PMC article.

7

Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma.

Tao Q, Lang Z, Li Y, Gao Y, Lin L, Yu Z, Zheng J, Yu S. Tao Q, et al. Among authors: lin l. BMC Cancer. 2023 Oct 24;23(1):1029. doi: 10.1186/s12885-023-11521-x. BMC Cancer. 2023. PMID: 37875823 Free PMC article.

8

Author Correction: LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition.

Zhan Y, Tao Q, Meng Q, Zhang R, Lin L, Li X, Zheng L, Zheng J. Zhan Y, et al. Among authors: lin l. Commun Biol. 2024 Jan 2;7(1):4. doi: 10.1038/s42003-023-05712-2. Commun Biol. 2024. PMID: 38168686 Free PMC article. No abstract available.

9

Ginsenoside Rg3 promotes hepatic stellate cell ferroptosis by epigenetically regulating ACSL4 to suppress liver fibrosis progression.

Hu Y, Lang Z, Li X, Lin L, Li Y, Zhang R, Zheng J, Yu Z. Hu Y, et al. Among authors: lin l. Phytomedicine. 2024 Feb;124:155289. doi: 10.1016/j.phymed.2023.155289. Epub 2023 Dec 16. Phytomedicine. 2024. PMID: 38176269

10

Ginsenoside Rb1 induces hepatic stellate cell ferroptosis to alleviate liver fibrosis via the BECN1/SLC7A11 axis.

Lin L, Li X, Li Y, Lang Z, Li Y, Zheng J. Lin L, et al. J Pharm Anal. 2024 May;14(5):100902. doi: 10.1016/j.jpha.2023.11.009. Epub 2023 Nov 29. J Pharm Anal. 2024. PMID: 38784156 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,691 results

Search Page

Filters